Form 8-K - Current report:
SEC Accession No. 0001213900-25-056997
Filing Date
2025-06-24
Accepted
2025-06-24 11:38:43
Documents
13
Period of Report
2025-06-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246693-8k_pmgc.htm   iXBRL 8-K 27577
2 PRESS RELEASE DATED AS OF JUNE 24, 2025 ea024669301ex99-1_pmgc.htm EX-99.1 10048
  Complete submission text file 0001213900-25-056997.txt   209029

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE elab-20250624.xsd EX-101.SCH 3026
4 XBRL LABEL FILE elab-20250624_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE elab-20250624_pre.xml EX-101.PRE 22366
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0246693-8k_pmgc_htm.xml XML 3797
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 251067347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)